Bruker EBITDA 2010-2024 | BRKR

Bruker EBITDA for the quarter ending December 31, 2024 was $0.125B, a 11.22% decline year-over-year.

  • Bruker 2024 EBITDA was 0.437B, a 20.82% decline from 2023.
  • Bruker 2023 EBITDA was 0.552B, a 5.81% increase from 2022.
  • Bruker 2022 EBITDA was 0.522B, a 3.8% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bruker EBITDA 2010-2024 | BRKR

  • Bruker 2024 EBITDA was 0.437B, a 20.82% decline from 2023.
  • Bruker 2023 EBITDA was 0.552B, a 5.81% increase from 2022.
  • Bruker 2022 EBITDA was 0.522B, a 3.8% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Kewaunee Scientific (KEQU)$95M
Harvard Bioscience (HBIO)$17M